Searching for just a few words should be enough to get started. If you need to make more complex queries, use the tips below to guide you.
Article type: Research Article
Authors: Palermo, Giovannia | Belli, Elisabettaa | Tommasini, Lucaa | Morganti, Riccardob | Frosini, Danielaa | Nicoletti, Valentinaa | Tognoni, Gloriaa | Siciliano, Gabrielea | Bonuccelli, Ubaldoa | Baldacci, Filippoa | Ceravolo, Robertoa; *
Affiliations: [a] Department of Clinical and Experimental Medicine, Unit of Neurology, University of Pisa, Pisa, Italy | [b] Section of Statistics, University of Pisa, Pisa, Italy
Correspondence: [*] Correspondence to: Prof. Roberto Ceravolo, MD, Neurology Unit, Department of Clinical and Experimental Medicine, University of Pisa, Building 13, Santa Chiara Hospital, Via Roma 67, 56122, Pisa, Tuscany, Italy. E-mail: [email protected].
Abstract: Background:Dementia with Lewy bodies (DLB) and Parkinson’s disease dementia (PDD) are differentiated by the time of onset of cognitive and motor symptoms (‘1-year rule’). We explored the neuropsychological continuum of DLB and PDD subjects with different timing of dementia onset. Objective:Our aim was to compare the neuropsychological profile of DLB and PDD patients with different timing of dementia onset. Methods:Neuropsychological findings at the diagnosis of dementia of 66 PDD and 42 DLB patients were retrospectively compared. Patients with PDD were divided into three tertile subgroups according to the time interval between the onset of parkinsonism and dementia (N = 24, 2–4 years; N = 17, 5–7 years; N = 25 ≥8 years, respectively). Results:DLB patients performed worse on the Stroop and semantic fluency tests than PDD, even in comparison to PD with early dementia onset. No significant differences among PDD subgroups were reported. Conclusion:Executive and semantic language tests could differentiate DLB and PD patients with earlier development of dementia relative to parkinsonism.
Keywords: Cognitive testing, dementia with Lewy bodies, Parkinson’s disease, ‘1-year rule’
DOI: 10.3233/JAD-210006
Journal: Journal of Alzheimer's Disease, vol. 84, no. 2, pp. 757-766, 2021
IOS Press, Inc.
6751 Tepper Drive
Clifton, VA 20124
USA
Tel: +1 703 830 6300
Fax: +1 703 830 2300
[email protected]
For editorial issues, like the status of your submitted paper or proposals, write to [email protected]
IOS Press
Nieuwe Hemweg 6B
1013 BG Amsterdam
The Netherlands
Tel: +31 20 688 3355
Fax: +31 20 687 0091
[email protected]
For editorial issues, permissions, book requests, submissions and proceedings, contact the Amsterdam office [email protected]
Inspirees International (China Office)
Ciyunsi Beili 207(CapitaLand), Bld 1, 7-901
100025, Beijing
China
Free service line: 400 661 8717
Fax: +86 10 8446 7947
[email protected]
For editorial issues, like the status of your submitted paper or proposals, write to [email protected]
如果您在出版方面需要帮助或有任何建, 件至: [email protected]